USA

iShares Evolved U.S. Innovative Healthcare ETF

The iShares Evolved U.S. Innovative Healthcare ETF (the “Fund”) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

$34.13

-5.3% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Evolved U.S. Innovative Healthcare ETF IEIH
Fund Size
$36.9 Million
Dividend
2.5%
Fees
-
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
Core U.S. Aggregate Bond ETF AGG
Fund Size
$100 Billion
Dividend
3.3%
Fees
0.03%
FTSE All-World ex-US Index Fund VEU
Fund Size
$52.9 Billion
Dividend
3.4%
Fees
0.07%
S&P 500 Equal Weight ETF RSP
Fund Size
$51.3 Billion
Dividend
1.6%
Fees
-
View 365 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $179 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.56 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5506
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 115.35
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -18.38
Profitable Companies 76
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 284.98
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 7.52
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 12.75
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 28.09
Enterprise Value to Revenue Enterprise value divided by revenue 12.29
Total Debt to Enterprise Value Total debt divided by enterprise value 0.54
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.246
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -466.82%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 21.17%
Return on Assets Indicates a company's profitability in relation to its total assets. 2.39%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 4.84%

Industries

Healthcare 87.4%
Industrials 0.7%
Consumer Staples 0.4%
Finance 0.4%
Consumer Discretionary 0.4%
Other 0.4%
Technology 0.4%
N/A 10.0%

Market cap

Micro Cap 6%
Small Cap 5%
Mid Cap 9%
Large Cap 47%
Mega Cap 34%

269 Investments

P/E-Ratio
Total Investment
Weight
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
10.0
Total Investment
$3.77 Million
Weight
10.2%
BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES logo

BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES

P/E-Ratio
n/a
Total Investment
$2.84 Million
Weight
7.7%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
135.3
Total Investment
$2.78 Million
Weight
7.5%
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
60.5
Total Investment
$2.24 Million
Weight
6.1%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
869.1
Total Investment
$2.12 Million
Weight
5.8%
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
12.4
Total Investment
$1.97 Million
Weight
5.4%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
28.1
Total Investment
$1.89 Million
Weight
5.1%
Moderna Inc logo

MRNA - Manufacturing

Moderna Inc

P/E-Ratio
-8.3
Total Investment
$1.66 Million
Weight
4.5%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
21.0
Total Investment
$1.61 Million
Weight
4.4%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
14.5
Total Investment
$1.48 Million
Weight
4.0%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
24.4
Total Investment
$1.46 Million
Weight
4.0%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
29.9
Total Investment
$913 Thousand
Weight
2.5%
Biogen Inc logo

BIIB - Manufacturing

Biogen Inc

P/E-Ratio
23.9
Total Investment
$843 Thousand
Weight
2.3%
Seagen Inc logo

SGEN - Manufacturing

Seagen Inc

P/E-Ratio
0.0
Total Investment
$672 Thousand
Weight
1.8%
Alnylam Pharmaceuticals Inc logo

ALNY - Manufacturing

Alnylam Pharmaceuticals Inc

P/E-Ratio
-41.5
Total Investment
$542 Thousand
Weight
1.5%
Horizon Therapeutics Plc logo

HZNP - Manufacturing

Horizon Therapeutics Plc

P/E-Ratio
0.0
Total Investment
$478 Thousand
Weight
1.3%
BioMarin Pharmaceutical Inc logo

BMRN - Manufacturing

BioMarin Pharmaceutical Inc

P/E-Ratio
101.4
Total Investment
$463 Thousand
Weight
1.3%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
19.8
Total Investment
$400 Thousand
Weight
1.1%
Royalty Pharma PLC logo

RPRX - Manufacturing

Royalty Pharma PLC

P/E-Ratio
11.0
Total Investment
$284 Thousand
Weight
0.8%
AstraZeneca PLC logo

AZN - Health Technology

AstraZeneca PLC

P/E-Ratio
35.6
Total Investment
$257 Thousand
Weight
0.7%
United Therapeutics Corp logo

UTHR - Manufacturing

United Therapeutics Corp

P/E-Ratio
11.3
Total Investment
$239 Thousand
Weight
0.6%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
52.8
Total Investment
$236 Thousand
Weight
0.6%
Jazz Pharmaceuticals PLC logo

Jazz Pharmaceuticals PLC

P/E-Ratio
n/a
Total Investment
$231 Thousand
Weight
0.6%
Biohaven Pharmaceutical Holding Co Ltd logo

Biohaven Pharmaceutical Holding Co Ltd

P/E-Ratio
n/a
Total Investment
$231 Thousand
Weight
0.6%
IQVIA Holdings Inc logo

IQV - Health Care and Social Assistance

IQVIA Holdings Inc

P/E-Ratio
30.4
Total Investment
$218 Thousand
Weight
0.6%